Healthcare -
Biotechnology - NASDAQ - US
$ 3.76
-0.529 %
$ 336 M
Market Cap
-8.55
P/E
TRVI - SHARES OUTSTANDING
Shares Outstanding TRVI - Trevi Therapeutics, Inc.
99 M
LAST VALUE
108.22%
2 YEAR CAGR
61.68%
5 YEAR CAGR
0.00%
10 YEAR CAGR